Tree thieves and millowner Indicted for theft of “Music Wood” with DNA Evidence
On Aug. 6, 2015, a Winlock, Washington wood buyer and his lumber mill plead guilty in U.S. District…
Benaroya Research Institute’s Carla J Greenbaum, MD was named chair of Type 1 Diabetes TrialNet
On Jul. 14, 2015, Benaroya Research Institute at Virginia Mason (BRI) announced that Carla J. Greenbaum, MD, had…
The Life Sciences Discovery Fund Authority was defunded
On Jun. 29, 2015, the Life Sciences Discovery Fund Authority (LSDF) was defunded by the Washington State Legislature,…
Washington Life Science History
Washington Life Science History is a poster that illustrates significant events in the development of the life science…
OHSU and Pacific Northwest National Laboratory team up to accelerate biomedical discovery
On May 6, 2015, Oregon Health & Science University (OHSU and the Department of Energy’s Pacific Northwest National…
Pacific Northwest National Laboratory constructed new chemistry facility
On Mar. 19, 2015, a contract was awarded to DGR Grant Construction of Richland, Washington, to build a…
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
Philanthropist Paul G Allen founded the Allen Institute for Cell Science with $100 million
On Dec. 8, 2014, philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create…
OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
Amgen announced closure of Seattle and Bothell facilities
On Jul. 29, 2014, Amgen announced the closure of facilities in Seattle and Bothell which resulted in the…
Biotechnology | Disease | FDA | Therapeutics
Omeros received FDA Approval of Omidria
On Jun. 2, 2014, Omeros received U.S. Food and Drug Administration (FDA) approval of Omidria for use in…
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
Benaroya Research Institute received 7-year award to lead Immune Tolerance Network
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
Juno Theraputics was founded
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
The Roux Prize was established
On Nov. 9, 2013, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington launched…
Matrical Bioscience acquired by Brooks Automation for $10 million
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
NanoString Technologies completed its IPO
On Jun. 25, 2013, NanoString Technologies launched an initial public offering at $10.00 per share and raised $54…
DNA analysis unearthed origins of Minoans, the first major European civilization
On May 14, 2013, a University of Washington led team announced that DNA analysis had unearthed the origins…
Genome of the coelacanth sequenced
On Apr. 17, 2013, researchers from the University of Washington, Broad Institute of Harvard and M.I.T. announced that…
Mountain pine beetle genome was decoded
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
Atossa Genetics completed its IPO
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
Washington State Secretary of Health declared a pertussis epidemic
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By June 16, the…
University of Washington Medical Center becomes first in PNW to discharge Total Artificial Heart patient
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Amnis Corp. was acquired by EMD Millipore
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
The FDA approved Seattle Genetics’ Adcetris (brentuximab vedotin)
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from Madigan Army Medical
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
HaloSource completed its IPO
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…